Annovis Bio Plans Three Presentations at CTAD Conference
Bitget2026/10/22 12:10- Annovis Bio will deliver three presentations at the Clinical Trials on Alzheimer's Disease conference in Boston, Nov. 16-19, 2026.
- An oral presentation on buntanetap's mechanism of action is scheduled for Nov. 19 at 3:52 p.m. ET.
- Posters cover buntanetap's pivotal early Alzheimer's study and AI-based drug evaluation, displayed Nov. 16, 2 p.m., through Nov. 17, 5:30 p.m. ET.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Wedbush interprets rumors of TSMC (TSM.US) CoWoS price increases: supply chain bottlenecks return, Intel (INTC.US) may face less competitive pressure.
According to reports, TSMC intends to increase the prices of its CoWoS packaging services. Wedbush believes this indicates that the technology has once again become a "bottleneck" in the supply chain.
Apple (AAPL.US) advances AI narrative: M6 new product performance maximized, Apple Intelligence plans for future paid model, Ives says market has not fully priced in
Apple released its latest 14-inch MacBook Pro and the new iMac on Tuesday. Yorkville Ives analyst Dan Ives gave a positive assessment of the news, maintaining his "outperform" rating on the stock with a target price of $400.
Crypto prices
More
